Simultaneous abdominal aortic replacement and thoracic stent-graft placement for multilevel aortic disease  by Moon, Marc R. et al.
Simultaneous abdominal aortic 
replacement and thoracic stent-graft 
placement for multilevel aortic disease 
Marc R. Moon,  MD,  R. Scott Mitchell, MD,  Michael D. Dake, MD,  
Chr istopher K. Zarins, MD,  James I. Fann, MD,  
and D. Craig Miller, MD,  Stanford, Calif. 
Purpose: Patients with aneurysmal disease involving both the descending thoracic and 
abdominal aorta have historically required simultaneous or sequential conventional 
operations, but the morbidity rate is high with either approach in these patients, who 
often exhibit coexisting cardiopulmonary disease. Transluminally placed endovascular 
grafts have recently been developed for repair of aortic aneurysms, and we have imple- 
mented these techniques to eliminate the need for a thoracotomy in patients with 
multilevel aortic disease. 
Methods: Since January 1994, 18 patients have undergone conventional bdominal aortic 
replacement with endovascular stent-graft placement into the descending thoracic aorta 
under fluoroscopic guidance through a 10 mm Dacron side limb offthe abdominal graft. 
Abdominal aortic replacement required a tube graft in eight patients and bifurcated 
grafts in 10 patients. Thoracic stent-grafts (custom fabricated, woven Dacron covered, 
self-expandable stents) averaged 12.2 + 4.2 cm (mean -+ SD) in length. 
Results: One patient died, resulting in a hospital mortality rate of 6%. No patients 
required further surgical intervention to treat their aortic disease. Seventeen patients 
(94%) are currently well 14 + 8 months after surgery (range, 3 to 29 months) with 
completely excluded thoracic aortic disease, no stent migration, and no change in stent 
configuration documented by serial radiologic examinations. 
Conclusions: Simultaneous abdominal aortic replacement and deployment of a thoracic 
stent-graft can safely exclude multilevel aortic aneurysmal disease and may be a valuable 
treatment option for these otherwise high-risk patients. (J Vasc Surg 1997;25:332-40.) 
Patients with multilevel aortic disease present a 
formidable challenge for the cardiothoracic and vas- 
cular surgeon and interventional radiologist. The 
morbidity rate of surgical repair can be substantial in 
these patients, who often exhibit coexisting cardio- 
pulmonary disease. In patients with an abdominal 
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aortic aneurysm, 5% also have a descending thoracic 
aneurysm~; in patients with a descending thoracic 
aneurysm, i3% to 29% also have abdominal involve- 
ment. 2-6 In the early 1980s, Crawford advocated 
simultaneous open thoracic and abdominal aortic 
repair as the treatment of choice in patients with 
multilevel aortic disease. 7,8 Sequential repair can also 
be performed, but this approach requires two major 
surgical interventions, and rupture of the residual 
aneurysm can occur while waiting the second opera- 
tion.S,7 Crawford fotmd that 30% of early postopera- 
tive deaths after isolated repair of a descending tho- 
racic aneurysm were caused by rupture of an 
untrcated infrarenal aneurysm, s 
Transluminally placed endovascular grafts have 
recently been developed for repair of  thoracic aortic 
aneurysms with encouraging early rcsults. 9a° In an 
attempt o decrease the risk associated with either a 
simultaneous thoracotomy and laparotomy or se- 
quential major operations in patients with multilevel 
aortic disease and to make treatment available to 
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patients with otherwise prohibitive comorbidities, 
we have begun to look at alternatives toconventional 
surgical treatment. In the current study, we found 
that combined retroperitoneal bdominal aortic re- 
placement with endovascular stent-graft placement 
into the descending thoracic aorta can effectively 
exclude both areas of aortic disease without the 
added morbidity of a thoracic incision or second 
operation. 
MATERIAL  AND METHODS 
Patient population. From January 1994 to 
March 1996, 18 patients with coexisting abdominal 
aortic and descending thoracic aneurysmal disease 
underwent conventional retropcritoncal bdominal 
aortic replacement and endovascular stent-graft 
placement into the descending thoracic aorta 
through a 10 mm Dacron side limb offthe abdomi- 
nal graft. A transperitoneal approach was used if 
necessary to adequately visualize the abdominal 
aorta. There were 14 men and 4 women, with a mean 
age of 71 + 6 (+ 1 SD) years (range, 62 to 83 years). 
Seventeen patients (94%) had significant comorbidi- 
ties that required treatment, including coronary ar- 
tery disease (12 patients), chronic obstructive pul- 
monary disease (COPD) (8), hypertension (15), and 
diabetes (3). Twelve patients (67%) had a significant 
smoking history (68 + 22 pack-years). During this 
period at our institution, one patient elected to un- 
dergo a simultaneous open thoracic and abdominal 
aortic aneurysm repair, and two other patients un- 
derwent sequential open repair 6 to 8 weeks apart 
because their thoracic aneurysm was not appropriate 
for stent-graft placement (inadequate proximal 
neck). 
Abdominal aortic disease including infrarenal (13 
patients), juxtarenal (3), and suprarenal (1) aneu- 
rysms, and one patient had severe aortoiliac occlusive 
disease. Ten patients had extensive disease of either 
one or both iliac arteries that required treatment. 
Mean abdominal aortic diameter in patients with 
aneurysms was 5.6 _+ 1.9 cm (range, 3.5 to 9.5 cm); 
10 aneurysms were greater than 5 cm and six were 
greater than 6 cm. Descending thoracic disease in- 
cluded atherosclerotic aneurysmal disease (12 pa- 
tients), intramural hematomaflpenetrating ulcer (5), 
and chronic post-traumatic aneurysm (1). The tho- 
racic aneurysm involved the distal descending aorta 
in five patients, mid-descending aorta in seven pa- 
tients, and proximal descending aorta in six patients. 
In three patients, the thoracic disease spanned all 
three segments. Length of the thoracic aneurysm 
averaged 8.9 _+ 4.3 cm (range, 3.2 to 20 cm). The 
mean diameter of the thoracic aneurysm (13 pa- 
tients) was 6.8 -+ 1.5 cm (range, 5 to 11 cm); only 
two aneurysms were less than 6 cm. Mean thoracic 
aortic diameter in patients with penetrating ulcers 
(five paticnts) was 5.5 + 0.5 cm (range, 5 to 6 cm). 
The thoracic aorta proximal to the diseased segment 
was 3.2 + 0.4 cm in diameter (range, 2.0 to 3.8 cm). 
The thoracic aorta distal to the diseased segment was 
also 3.2 + 0.4 cm in diameter (range, 2.4 to 3.8 cm). 
Preoperative valuation. Before surgery, a spi- 
ral computed tomographic (CT) scan was obtained 
of the thoracoabdominal aorta to measure thoracic 
and abdominal aortic diameter, evaluate the branch 
vessels and iliac arteries, and provide a three-dimen- 
sional reconstruction of the descending thoracic 
aorta to measure aneurysm length and diameter. An 
aortogram was obtained to identify the rcnal and 
visceral vessels and to determine the relationship of 
the proximal thoracic aneurysm neck to the left sub- 
clavian artery and celiac axis. One to 2 cm ofnonan- 
eurysmal aorta is necessary both proximal and distal 
to the aneurysm to allow safe deployment without 
the need for a preliminary subclavian-to-carotid 
transposition or bypass and without compromise to 
the visceral circulation. 1°,11 It is also helpful to local- 
ize patent intercostal rteries o that attempts can be 
made to preserve these at the time of stent-graft 
deployment; we do not, however, perform selective 
intercostal ngiographic evaluation. I f large intercos- 
tal arteries are noted before surgery, excess distal 
stent-graft length is avoided to prevent intercostal 
occlusion; alternatively, an uncovered stent can be 
used to anchor the stent-graft at the proximal or 
distal neck of the aneurysm, allowing perfusion in a 
critical intercostal artery. Patients were not consid- 
ered appropriate for endovascular stent-graft place- 
ment in the absence of an adequate aneurysm neck 
(inadequate l ngth or excess diameter) or with inap- 
propriate morphologic features (e.g. extensive 
chronic aortic dissections). 
Fabrication of  endovascular stent-grafts. 
Stent-grafts were individually fabricated as previously 
described with commercially available products. 911 
Multiple self-expanding "Z"-stents were combined 
to yield the desired length, and a woven Dacron graft 
(Cooley Veri-Soft, Meadox Medicals, Inc., Oaldand, 
NJ.) ,  that had been ironed to flatten the crimps and 
reduce its profile was attached to the stainless-steel 
endoskeleton with interrupted 5-0 polypropylene su- 
tures (Fig. 1). Uncrimped grafts are now available 
and will be used for stent-graft fabrication in the 
future. On the basis of preoperative CT scan mea- 
surements, tent-graft length was manufactured to
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Fig. 1. Endovascular stent-graft. Woven Dacron graft se -
cured to a stainless-steel ndoskeleton with polypropylene 
sutures. 
be approximately 3 to 4 cm longer than the segment 
of aortic disease; this allowed the ends of the stent- 
graft to anchor to the proximal and distal necks of 
the aneurysm. Stent-graft diameter was oversized by 
2 to 3 mm to create an effective friction seal at each 
end. Stent-grafts could be designed to taper or re- 
verse-taper as necessary to match each patient's anat- 
omy. After sterilization, the stent-graft was radially 
compressed and loaded into a 20F to 28F Teflon 
sheath (loading cartridge) for later deployment. 
Surgical technique. A double lumen endotra- 
cheal tube was usually inserted, and cardiopulmonary 
bypass tandby was available for every case. Continu- 
ous radial artery and pulmonary artery monitoring 
were used, as was transesophageal chocardiography 
to monitor cardiac function. Patients were prepped 
and draped for combined thoracic and retroperito- 
neal incisions in the 60-degree right lateral decubitus 
position. A cell-saver collection system was helpful to 
minimize transfusion requirements during aortic re- 
placement and catheter manipulation. Abdominal 
aortic replacement was performed using a standard 
retroperitoneal approach; rarely was a transperitoneal 
approach necessary for adequate visualization of the 
abdominal aorta. With moderate systemic hepa- 
rinization (100 IU/kg),  the abdominal aorta was 
replaced with a Dacron tube graft in eight patients, 
aortobiiliac graft in eight patients, aortobifemoral 
graft in one patient, and the remaining patient re- 
quired a bifurcated graft to the left iliac and the right 
femoral artery. The patient with a suprarenal aneu- 
rysm had previously undergone an aortobifemoral 
graft for occlusive disease and required supraceliac 
cross-clamping and renal reimplantation. In all pa- 
tients, after completion of the distal anastomosis, a 
10 mm Dacron graft (length, approximately 10 to 15 
cm) was anastomosed in an end-to-side fashion to 
the main trunk of the abdominal graft (Fig. 2). The 
distal end was then secured with a vessel clamp. The 
graft was then used as the side limb through which 
the stent-graft could be placed. If a bifurcated graft 
was required, it was also possible to use one limb of 
the graft (9 mm or greater) for endovascular ccess, 
although use of a side limb is preferable as it allows 
earlier eturn of flow to both legs. 
Endovascular stent-graft placement. Before 
endovascular manipulation, full systemic hepariniza- 
tion (total 200 to 300 IU/kg) was achieved. Using 
the Seldinger technique, a 9F introducer sheath was 
inserted into the side limb graft, a 5F pigtail was 
introduced into the aortic arch over a guidewire 
under fluoroscopic guidance, and an intraoperative 
angiogram was obtained to accurately localize the 
proximal aneurysm neck. A portable C-arm image 
intensifier with digital road-mapping capabilities was 
used. A 0.035-inch "super-stiff" guidewire was then 
exchanged for the introducer, and the proximal side 
limb was clamped to prevent blood loss. A carefully- 
sized transverse incision was made in the side limb to 
allow passage ofa 20F to 28F Teflon delivery sheath 
with a tapered ilator over the guidewire. The deliv- 
ery sheath had a fenestrated plastic cover (one-way 
valve apparatus, Cook Urological, Inc., Blooming- 
ton, Ind.) secured to its end to provide hemostatis; 
the one-way valve allowed antegrade catheter inser- 
tion but prevented retrograde blood loss during 
catheter exchanges. The dilator and guidewire were 
removed and the compressed stent-graft introduced 
into the delivery sheath with a solid Teflon rod or 
"pusher." 
Under fluoroscopic guidance, the stent-graft was 
advanced up the delivery sheath using the Teflon 
pusher until it was 1.5 to 2 cm proximal to the 
aneurysm neck. The location of the proximal neck 
was based on landmarks obtained on the intraopera- 
tive angiogram. Fortunately, the anatomy of the dis- 
tal aortic arch and proximal descending thoracic 
aorta was relatively stable during passage of the deliv- 
ery sheath. If anatomic deformation by the sheath 
was suspected, another angiogram was obtained 
through the sheath prior to stent-graft deployment. 
Controlled hypotension wasinduced with nitroprus- 
side or esmolol (mean arterial pressure, 50 to 60 mm 
Hg) to minimize stent migration during deploy- 
ment. To deploy the stent, the delivery sheath was 
withdrawn rapidly while the pusher was held station- 
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Fig. 2. Dacron side limb anastomosed to left limb of an aortoiliac graft (transperitoneal 
approach). 
ary; the stent-graft emerged from the sheath in the 
proper position. A completion angiogram was then 
obtained to assure aneurysm exclusion. 
I f  stent-graft position was too distal such that the 
proximal aneurysm was not excluded, or it was too 
proximal such that the distal aneurysm was not ex- 
cluded, additional smaller stent-grafts were placed to 
bridge the gap. After removal of all catheters and 
heparin reversal, the side limb was over sewn near its 
anastomosis to the abdominal graft, the incision was 
closed, and the patient was traalsferred to the inten- 
sive care unit. I f  further manipulation was considered 
in the future (i.e., for treatment of other aneurysms 
that currently were not of adequate size to warrant 
intervention), the side limb was left intact and buried 
just below the fascia or in the subcutaneous tissue for 
easy access. 
Postoperat ive evaluation. Before discharge, 
aortography and a repeat spiral CT scan were per- 
formed to document aneurysm exclusion. The pa- 
tients were then studied at 2 months with a chest 
radiograph, at 6 months and 1 year with a radio- 
graph, spiral CT scan, and arteriogram, then annually 
thereafter with a radiograph and spiral CT scan. Figs. 
3, 4, and 5 depict typical preoperative and postoper- 
ative studies in an 83-year-old man who underwent 
simultaneous transperitoneal bdominal aortic re- 
placement and descending thoracic aortic stent-graft 
placement hrough a side limb off the abdominal 
graft. Total exclusion of the patient's 11 cm thoracic 
and 5 cm abdominal aneurysms was achieved. 
The operative and radiologic protocol was ap- 
proved by the Stanford University Medical Center 
Committee on the Use of Human Subjects in Re- 
search, and informed consent was obtained before 
surgical intervention and radiographic studies. 
Statistical analysis. All continuous data are re- 
ported as mean + one standard eviation and ratios 
as mean _+ 70% confidence limits. Actuarial life-table 
survival data were calculated using commercially 
available software (SPSS, Chicago, Ill.) and variabil- 
ity expressed as _ one standard error of the mean. 
RESULTS 
Stent-graft deployment was technically successful 
in all cases; 13 patients were adequately treated with 
one stent, whereas five patients required two stent- 
grafts to exclude the area of  disease. Mean stent-graff 
length was 12.2 + 4.2 cm (range, 7.5 to 20 cm) and 
diameter was 3.3 + 0.4 cm (range, 2.4 to 3.8 cm). 
Complete aneurysm exclusion was achieved at the 
time of operation in 17 patients (94%) and have 
remained so throughout the follow-up period. One 
patient has a residual false channel between the stent- 
graft and native aortic wall proximally that remains 
unchanged 21 months after surgery. This 66-year- 
old man, who was refused an open thoracic repair 
because of severe COPD, underwent stent-grafting 
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Fig. 3. Preoperative thoracic (A, magnified) and abdominal (B) cross-sectional contrast CT 
scans demonstrate 11 cm and 5 cm aneurysms, respectively, in an 83-year-old man. 
for two large penetrating ulcers. At the completion 
of  the procedure, an angiogram demonstrated that 
the ulcers were excluded, but there was also a small, 
low-flow residual false channel. We are currently ob- 
serving this patient at 6-month intervals with con- 
trast CT scans. I f  the aorta enlarges, a saccular false 
aneurysm develops at either end of  the stent-graft, or 
flow is reestablished to the ulcers, additional stent- 
grafts will be placed. No  patients have required fur- 
ther surgical intervention to treat their aortic disease. 
Overall, one patient died, resulting in a hospital 
mortality rate o f  6% + 6%. The one postoperative 
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Fig. 4. Postoperative thoracic (A) and abdominal (B) aortograms obtained from the same 
patient in Fig. 3 after combined transperitoneal abdominal aortic replacement and descending 
thoracic stent-graft placement. 
death occurred in a 66-year-old man 31 days after 
complex redo suprarenal aneurysm resection and 
thoracic stent-grafting; splenectomy was required on 
the first postoperative day for an intraoperative in- 
jury. The postoperative course was complicated by a 
severe coagulopathy and systemic hypotension re- 
quiring inotropic agents; the patient ultimately died 
offungal sepsis with multisystem organ failure. In the 
17 survivors, hospital stay, intensive care unit stay, 
and mechanical ventilation averaged 12 + 9 days, 
5 _+ 5 days, and 3 -+ 4 days, respectively. Thirteen 
patients (72%) were extubated within 48 hours, and 
nine (50%) required less than 72 hours of intensive 
care. Intraoperative transfusion requirements were 
3.7 _+ 3.1 units (packed red blood cells), and, exclud- 
ing the patient who died with a prolonged coagu- 
lopathy that required 79 units in the postoperative 
period, mean postoperative transfusion requirements 
were 2.6 -+ 2.2 units. 
Nine postoperative complications occurred in 6 
patients (33%), including respiratory insufficiency, 
small bowel obstruction requiting laparoscopic lysis 
of adhesions, cerebrovascular accident, paraplegia, 
coagulopathy (two patients), splenic injury, dissec- 
tion of the aorta proximal to the stent-graft, and 
retroperitoneal hematoma that required surgical 
evacuation 3 months aftcr surgery. 
A 62-year-old man with severe COPD required 
18 days of ventilatory support for respiratory insuffi- 
ciency before full recovery. This patient also had a 
retrograde subintimal aortic dissection proximal to 
the level of stent-graft placement on his predischarge 
CT scan. He remained asymptomatic, and subse- 
quent CT scans and arteriograms demonstrated 
complete resolution within 4 months. 
A 72-year-old woman with a history of transient 
ischemia attacks but no radiologic evidence of ca- 
rotid disease developed a left hemispheric stroke 9 
hours after the procedure. A brain CT demonstrated 
multiple old bilateral infarcts; a residual eft-sided 
strength deficit persists. Paraplegia occurred in the 
66-year-old patient described above as the operative 
death. This patient had a 12.5 cm stent-graft placed 
into the thoracic aorta. It is unknown whether distal 
embolization, hypotension, or intercostal artery in- 
terruption was responsible for the spinal cord injury 
in this patient. 
A 74-year-old woman with no preexisting hema- 
tologic disorder suffered a severe thrombotic oagu- 
lopathy during abdominal aortic replacement. Prox- 
imal aortic and distal iliac thrombosis occurred after 
suprarenal cross-clamping to repair her juxtarenal 
aneurysm despite adequate anticoagulation; acti- 
vated clotting time was 280 seconds at the time of 
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Fig. 5. Postoperative cross-sectional contrast CT scan 
(magnified) of the thoracic aneurysln in the patient de- 
picted in Figs. 3 and 4. Note the presence of contrast 
within the stent-graft and absence of contrast within the 
aneurysm sac demonstrating complete xclusion of the 
thoracic disease. 
thrombosis (120 seconds baseline). Thrombectomy 
was required to restore distal flow. Due to the intra- 
operative complication and prolonged suprarenal 
cross-clamp time (89 minutes), stent-graft placement 
was deferred to a later date (19 days after surgery) on 
a second admission. At the initial operation, the 
Dacron side limb was tunneled through the fascia 
into the subcutaneous plane. When the patient re- 
turned to the operating room, relaparotomy was not 
required; a subcutaneous dissection allowed easy ac- 
cess to the side limb, which, after thrombectomy, 
allowed routine stent-graft placement. Hospital stay 
was 7 days after the abdominal aneurysm resection 
and 4 days after stent-graft placement. All other 
patients underwent stent-graft placement during the 
same anesthetic period. 
There have been no late deaths to date, and all 17 
hospital survivors are currently well 14 -+ 8 months 
(range, 3 to 29 months) after surgery. The actuarial 
survival rate is 92% _+ 8% at 12 months. Postoperative 
serial radiographic studies have demonstrated no 
stent migration or change in stent configuration i  
the thoracic aorta and no pseudoaneurysm formation 
or aneurysm expansion in either the abdominal or 
thoracic aorta. Approximately one half of the patients 
have experienced shrinkage of the thrombosed tho- 
racic aortic aneurysm sac, whereas in the others its 
size has remained the same. 
DISCUSSION 
Endovascular stent-grafts have recently been de- 
veloped to exclude disease of the descending thoracic 
aorta, and although long-term follow-up is limited, 
early experimental nd clinical results have been en- 
couraging. 9,1°,12,13 Since July 1992 stent-graft repair 
for descending thoracic aortic disease has been per- 
formed at Stanford in 81 patients, n The overall hos- 
pital mortality rate is 9% + 3%, the paraplegia rate is 
4% +_ 2%, and the stroke rate is 5% + 3%. Current 
actuarial survival estimates are 87% _+ 4% at 1 year 
and 81% _+ 6% at 3 years, but mean follow-up is only 
13.2 months. In an attempt to decrease the morbid- 
ity rate associated with combined descending and 
abdominal aortic replacement that requires both a 
thoracotomy and laparotomy, we have applied endo- 
vascular techniques to patients with multilevel aortic 
disease. 
The operative mortality rate for patients under- 
going elective open repair of an isolated escending 
thoracic aortic aneurysm is 3% to 12% 6'14-18 whereas 
that following conventional bdominal aortic resec- 
tion is 2% to 5%. 19-22 Historically, in patients with 
combined escending thoracic and abdominal aortic 
aneurysms, both could be repaired simultaneously 
through separate incisions or the operations could be 
staged, usually 6 to 8 weeks apart, with the order of 
operation determined by symptoms and relative an- 
eurysm size. In asymptomatic patients, Crawford rec- 
ommended repair of the thoracic aorta initially. 7-s 
While awaiting the second operation, the abdominal 
aneurysm is easier to observe, and if symptoms or 
rupture occur patients could potentially survive for 
periods sufficient to attempt repair. In contrast, tho- 
racic aneurysms are more likely to rupture without 
warning and are rapidly fatal within minutes. 
More than 60% of patients who undergo repair of 
a descending thoracic aneurysm have multifocal aor- 
tic disease, half of which involves the infrarenal aor- 
ta. 7 Crawford s noted in his series of 112 patients who 
underwent isolated repair of a descending thoracic 
aneurysm, that of 10 patients who died within 30 
days of operation, 30% died as the result of a rup- 
tured infrarenal aneurysm. For  these reasons, Craw- 
ford performed simultaneous repair through separate 
thoracic and abdominal incisions in 24 patients who 
he felt were good surgical risks and continued to do 
well in the operating room after the first replace- 
ment; the 30 day mortality rate was 8%. 7 In his series, 
the mortality rates in patients who underwent simul- 
taneous versus taged operations for all types of mul- 
tilevel aortic disease were 10% and 16%, respectively. 
In the current series, our mortality rate was 6% + 
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6%, which compares favorably with Crawford's re- 
sults; however, many of these patients had been con- 
sidered inoperable for standard thoracic aortic re- 
placement by cardiovascular surgeons before surgery 
because of their poor underlying cardiopulmonary 
status. In patients of acceptable surgical risk, we 
currently recommend thoracic aortic replacement 
(either open or endovascular) in all symptomatic 
patients or if the aneurysm is greater than 6 cm or 
twice the size of a relatively normal contiguous aortic 
segment. 6 Penetrating ulcers or documented en- 
largement should also prompt surgical considcration. 
Concurrent abdominal aortic replacement should be 
considered if it is greater than 5 cm, if it has been 
increasing in size, or if the patient's associated il- 
iofemoral disease precludes afe access to the more 
proximal aortic tree (extensive intraluminal throm- 
bus or atherosclerotic disease). In our series, five 
patients had aneurysms between 4 and 5 cm, four 
between 5 and 6 cm, and six had large aneurysms 
(greater than 6 cm). Two patients had smaller aneu- 
rysms (3.5 cm each) that would not have been re- 
paired, but iliofemoral atherosclerotic disease pre- 
vented safe passage of the stent-graft insertion 
system. 
Conventional descending aortic resection is asso- 
ciated with a 5% risk of severe renal dysfunction that 
requires dialysis, 6,1s whereas the risk is less than i% 
with elective infrarenal replacement. 19-23 Because 
thoracic stent-grafting does not require a suprarenal 
cross-clarnp (minimizing distal aortic hypotension), 
there should be no added risk of renal dysfunction 
over that associated with abdominal aneurysm resec- 
tion alone, with the possible exception of contrast- 
induced nephropathy. One patient in our series de- 
veloped renal dysfunction in association with 
multisystem organ failure after edo suprarenal neu- 
rysm repair. This was most likely related to suprarenal 
cross-clamping with renal reimplantation, contrast- 
induced nephropathy, sepsis with systemic hypoten- 
sion requiring inotropic support, and a severe coagu- 
lopathy in the postoperative p riod. 
Although thc risk of paraplegia with abdominal 
aortic replacement is minimal (0% to 0.2%), 23,24 the 
incidence with descending thoracic replacement av- 
erages 4% (range, 0% to 18%; 4% at our institu- 
tion). 3,6,14,18 With stent-grafts, the opportunity to 
reimplant intercostal vessels is not available, but the 
aorta does not need to be clamped, thus avoiding 
distal hypotension during the operation. One patient 
in our series was noted to be paraplegic in the early 
postoperative period. After redo suprarenal aneu- 
rysm repair, a 12.5 cm stent-graft was placed from 
the proximal to distal descending aorta. In this par- 
ticular patient, there was no evidence of critical inter- 
costal arteries near the aneurysm on preoperative 
studies, but selective intercostal ngiography was not 
performed. The artery of Adamldewicz is present in 
80% of patients, and when present it arises between 
T9 and T12 in 75%, between L1 and L2 in 10%, and 
between T5 and T8 in 15%. 6 In chronic thoracic 
aneurysms, the intercostal rteries usually thrombose 
within the diseased segment, leaving the spinal cord 
dependent on proximal and distal collateral vessels. I f  
intercostal rteries are noted angiographically before 
the procedure, excess distal stent-graft length should 
be avoided to prevent occlusion. Uncovered stents 
can also be used as the proximal or distal anchor for 
patients in whom stent-graft location is sufficiently 
close to an important intercost~d artery, although this 
is less desirable. Whether paraplegia in our patient 
was a result of distal embolization or obliteration of 
an unidentified intercostal rtmT or intraoperative or
postoperative hypotension remains unknown. 
Combined conventional abdominal aortic re- 
placement with descending thoracic aortic stent- 
graft placement is feasible and can safely be per- 
formed in high-risk patients who otherwise may not 
be considered candidates for open repair. Although 
long-term results remain unknown, we believe that 
the early results are encouraging and warrant further 
investigation and application of this new approach: 
We are continuing to monitor these patients and 
perform this procedure as part of an investigational 
protocol approved by the Institutional Review Board 
of the Stanford University Medical Center, and an 
application for an Investigational Device Exception 
has been submitted to the Food and Drug Adminis- 
tration. The 1-year actuarial survival rate of 92% _+ 
8% compares favorably with that of patients who 
undergo isolated standard descending thoracic repair 
(85 %) and patients with multifocal aortic disease who 
undergo replacement of both aneurysms (75%) or 
only one aneurysm (5 5%).3,6,7,14,16 It is interesting to 
note that in patients who underwent planned resec- 
tion of only one aneurysm, the 3-year and 7-year 
survival rates were 48% and 12%, respectively, com- 
pared with 32% and 2% for patients who received no 
treatment but 64% and 34% in patients who under- 
went resection of both aneurysms. 7 Thus complete 
repair of multilevel disease portends the best long- 
term prognosis and should be the treatment of 
choice, but their 7-year survival rate of only 34% 
underscores the poor general medical status of even 
the best candidates for combined resection. 
The less-invasive approach described in this re- 
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port may be associated with fewer early complica- 
tions and deaths than simultaneous or sequential 
open thoracic and abdominal repair in high-risk pa- 
tients, but the long-term efficacy and clinical out- 
come remains entirely unknown. Long-term studies 
will be required before this approach can bc adopted 
in all patients with multifocal aortic disease or in 
anything other than an experimental protocol. In a 
young patient who is otherwise healthy, conven- 
tional open repair of a concurrent thoracic and ab- 
dominal aneurysm, either simultaneous or staged, 
may provide the best opportunity for long-term suc- 
cess. Elderly patients with coexisting cardiopulmo- 
nary disease would most benefit from a less-invasive, 
but nonetheless complete, repair of this challenging 
disease. 
We gratefully acknowledge Phoebe E. Taboada for her 
help in preparing the manuscript and Kathleen A. Moore, 
BS, for statistical consultation. 
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